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1. Introduction 
During the last years, many local and regional techniques have been introduced, helping, 
together with surgery, to treat the hepatocellular carcinoma, and contributing to an 
important improvement of disease free survival and overall survival of patients affected by 
this disease. These techniques, suitable also for metastatic lesions, can be performed as 
exclusive ones or following surgery, and help controlling tumor progression even when it is 
over any possible surgical approach. 
Local and regional therapies can be divided into two groups: in the first one we can consider 
the techniques using heat to obtain their effect, in the second one we consider those using 
chemotherapic drugs to obtain necrosis of the neoplastic tissue. Necrosis can be obtained 
through the energy produced by radiofrequency probes, through the alcohol or acetic acid 
injection or through the injection of embolyzing substances, also together with 
chemotherapic drugs,  into the hepatic artery. Last but not least, the injection of yttrium 
labeled microspheres is available. These are injected into the hepatic artery  and are able to 
cytoreduce the tumor through a local irradiation. 
2. Description 
The most important techniques nowadays available are: 
2.1 Percutaneous ethanol injection 
This is the oldest technique, and it consists in the percutaneous injection of absolute ethanol 
into the lesion using a fine needle provided with one or more infusion holes. Ethylic alcohol 
is able to induce a neoplasm coagulative necrosis through cellular dehydration and protein 
denaturing. Moreover, it causes vascular thrombosis with occlusion of the small vessels 
which normally feed the tumor. This is a feasible technique for small lesions under 2 
centimeters of diameter. Considering these lesions, ethanol has demonstrated its ability to 
induce a necrosis of more than 95 % of the tumor volume. This result is absolutely similar to 
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the one obtained with more recent techniques like radiofrequency ablation, which on the 
contrary gets better results if used on bigger nodules. In facts, in case of lesions 2-5 cm of 
diameter, PEI is able to produce a necrosis of just 50% of the neoplasm volume, and this 
percentage becomes inessential in case of even bigger cancers. On the contrary, even today 
PEI grants a curability percentage similar to that given by radiofrequency or advanced 
percutaneous techniques if we consider little HCCs. 
Difficulties shown by PEI in treating medium and big lesions are characteristic of the 
injected drug: ethanol is not able to diffuse equally into the tumor, as it can not degrade the 
fibrous septa which are diffused into the nodule. In a 33% of cases these septa may cause a 
variable distribution of the drug in the lesion, and then a higher risk of relapse of disease. 
Moreover, big nodules are often well supplied of blood, and also blood circulation may 
determine a rapid ethanol wash out from the injected site, lowering the therapeutic effect of 
PEI. Even if PEI is a ultrasound-guided technique, the needle might be inserted in the 
peripheral part of the nodule, and then its farthest zones might not receive an adequate 
concentration of drug. In the end, percutaneous ethanol injection has a limited diffusion 
outside the lesion, and then it’s not amenable to grant an adequate volume of oncologic 
safety based on healthy hepatic tissue around the tumor. This area has normally the highest 
probability to hide satellite nodules1,2,3. 
Percutaneous ethanol injection is a safe technique, easy, usually well tolerated and feasible 
also under local anesthesia in outpatients. Sometimes some sessions of therapy are required 
to achieve a positive oncologic result: most of the protocols schedule eight sessions, once or 
twice a week, for a whole amount of one or two months of treatment. Complications are 
linked to the particular kind of technique and to the treated organ: hepatic hematomas, 
hemoperitoneum, and alcohol diffusion in the blood vessels are the most probable of them, 
anyhow they are rare and easy to control. Worse complications are described in the 
Literature in a 0-2% of cases. Among them the tumor seeding along the needle path is 
included, and this event may happen during all the percutaneous treatments of neoplasm 
lesions1,4. 
3 years and 5 years survival after exclusive treatment are respectively 22% and 0% 
2.2 Percutaneous acetic acid injection 
Technically similar to the previous, acetic acid is able to enter easily into the cells, dissolve 
its lipids and destroy collagen. Acetic acid is used in a solution, and its efficacy rises as its 
concentration rises, until a plateau is reached when the concentration of drug is about 50%. 
This level has been defined during studies on mice, the exact one in humans has never been 
detected. Acetic acid has a cytotoxic effect three times higher than ethanol, and this is the 
reason why it reaches the same therapeutic result needing a lower number of sessions, 
improving patient’s comfort and minimizing the risk of complications. PAI is in the end 
useful also for bigger lesions than those treated with PEI, as acetic acid spreads into the 
nodule through the collagen destruction1,3. 
In spite of these qualities, PAI is nowadays almost abandoned, turning to the advantage of 
modern techniques. There are many reasons for this: a remarkable risk of toxicity for 
intravascular diffusion of acid, considerably higher than the one linked to ethanol, risk of 
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tumor seeding along the needle path4, high level of pain (higher than the one linked to PEI) 
and then all the risks linked to the puncture of a high vascularized parenchyma, like the 
hepatic one, typical of every percutaneous treatment. 
Percutaneous acetic acid injection seems more effective than PEI under a therapeutic point 
of view: the low pH characteristic of the acid is able to destroy any septum into the nodule, 
and so tumor necrosis is more homogeneous and safe. For this reason, PAI is healing as 
much as PEI and radiofrequency ablation if we consider small volume lesions, granting 
percentages of necrosis close to 95% if nodules are less than 2 cm of diameter5,6. In this case 
and in selected groups disease free survival rate is 100% and 92% respectively at 1 and 2 
years (Ohnishi et al.), noticeably higher than the one linked to PEI.  
3 years and 5 years survival, on the contrary, after exclusive treatment are respectively 40% 
and 0%6. 
2.3 Radiofrequency ablation 
Radiofrequency ablation is a technique that induces tissue necrosis through cellular 
dehydration following a local heat growth. During this procedure, the patient is a part of a 
real and proper electric circuit, which comprises a generator, a needle to be inserted into the 
neoplasm, a wide surface plate to be used as an electric outflow, and of course patient’s 
tissues. Heat growth is directly depending on tissue impedance against electric flow, 
measured in Ohm: as it is quite high, in the immediate surroundings of the entry point into 
the patient (the needle) a frictional verifiable thermic increase develops. It causes a 
coagulative necrosis of treated tissues, with a curative effect. Radiofrequency waves swing 
between 300 KHz and 2500 MHz, and the amount of necrotized tissue is depending on the 
heat, the time of exposure and the needle caliber. 
A key point for a good radiofrequency procedure is the possibility to control the level of 
temperature reached during the treatment. In facts, a 55 degrees local temperature, kept for 
4-6 minutes, is able to cause an irreversible cellular damage and then apoptosis. A 60-100 
degrees local temperature causes an immediate tissue coagulation, as like as the one caused 
by an electrical scalpel during hemostasis, and then a mythocondrial and cytoplasmic 
enzymes damage, with a sudden cellular death. A temperature over 100 degrees induces 
tissue vaporization and carbonization5.  
These different reactions must be considered under the point of view of the different ability 
damaged tissues have to transmit electricity. At a first time a neoplastic carbonization might 
seem a valid and final result, but it’s fundamental to consider that a carbonized tissue has a 
higher resistance to electric flow than a damaged or healthy one, and then it provides a 
protective effect to the surrounding structures, which are shielded from any electric 
exposure. This is the reason why the technique is ineffective if a tissue carbonization 
happens around the needle. 
The system allows to control the temperature reached into the area under treatment, thus 
avoiding this event. The temperature effective to treatment ranges between 55 and 100 
degrees. Needles contain a probe, and any thermic growths are recognized through the 
continuous measurement of system impedance, direct function of heat growth and tissue 
change of state. In case of growth, this may be controlled through reducing the energy given 
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to the patient. Due to this, the complete time of treatment might grow up from 4-6 minutes. 
In our clinical experience, the medium length is about 10-12 minutes, but in some centers 
sessions lasting up to 30 minutes are performed. 
Radiofrequency ablation therapy is a good option in hepatocellular carcinomas either 
alone, or in combination with surgery, and, even having different technical principles, it is 
a valid and modern alternative to percutaneous ethanol injection. It is able to reach the 
same results even through a lower number of treatment sessions, also for lesions more 
than 2 centimeters of diameter, or metastatic. Especially in these cases this technique has 
its best advantages in comparison to PEI, and represents a step forward in comparison to 
other percutaneous procedures. 
Using a single needle, the volume of treated hepatic tissue is quite narrow, about 1.8 cm3. 
This volume may be enhanced using more powerful generators and needles chilled with 
saline, which allows a tissue impedance reduction and a growth of heat diffusion and 
energy delivery. Then, the use of multiple needles or single hooked needles is possible5,7.  
Using these devices, the treated volume may rise up to 3 cm3 and over. It’s better in any case 
to use a single hooked needle, as it grants a similar treated volume if compared to multiple 
needles, but it has a bigger treatment evenness. 
 
Fig. 1. Radiofrequency over resected liver 
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Radiofrequency is a versatile technique. It may be provided as an exclusive treatment, 
through percutaneous needle insertion, or it may follow surgery during an operation as a 
way to treat satellite lesions or to eliminate metastatic liver nodules during non hepatic 
surgery. Radiofrequency ablation as an exclusive technique may be provided under local 
anesthesia or conscious sedation. In some centers radiofrequency is used during surgery as a 
way to treat the surgical resection surface: it allows a coagulative necrosis of surface cells, 
thus providing a bigger oncologic safety than that obtained through resection itself. 
Radiofrequency has a number of possible complications, linked to the needle insertion into 
the nodule and to the necrosis following the treatment. Complications described in 
Literature are, in order of probability, hepatic hematomas or hemoperitoneum needing 
blood supply, hepatic abscesses caused by necrosis infection and needing percutaneous 
drainage, thermic bile duct damages needing biliary drainage, hemothoraxes, bowel 
perforations caused by needle mispositioning, necrosis of organs close to liver due to 
thermic damage (especially when treating superficial liver lesions), hepatic failure. 
Neoplastic seeding along the needle path is quite high as a risk (about 2% of procedures), 
but it can be avoided keeping the system working during the needle extraction, and then 
performing a real and proper radiofrequency ablation over the tissues which have been in 
contact to the needle itself. To reach a good result, a temperature of about 75 degrees is 
important. 
 
Fig. 2. A typical lesion suitable for radiofrequency during surgery 
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The strongest limit of this procedure is the presence of blood vessels more than 5 mm of 
diameter nearby the target lesion. Vessels can reduce the treatment efficacy through heat 
loss, and may be impossible to reach the 55 degrees temperature mandatory for the 
technique to be effective. Moreover, even if it’s more effective than the previously described 
techniques, also radiofrequency is affected by the presence of collagen septa into the 
nodules: even if it’s true that heat can destroy collagen, these septa can shield the tissue 
behind them form thermic effects. This is the reason why it’s always impossible to predict 
the exact final amount of treated volume.  
In the end, the only possibility to be certain to avoid any tumor relapse is to be sure to have 
destroyed every neoplastic cell. This is of course impossible. Heat damage induces the 
production of tissue growth factors by the cells surrounding the damaged ones, and these 
substances are the most important factors of disease relapse if any tumor cell survived the  
 
Fig. 3. A lesion suitable for percutaneous radiofrequency 
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procedure. This is the reason why 3 and 5 years survival rates after exclusive treatment are, 
respectively, 56-83% and 40-52%. Anyways, these rates are similar to surgical ones in case of 
surgery following disease relapse. This is the reason why, in these cases, nowadays 
radiofrequency ablation is a valid exclusive treatment8. 
2.4 Cryotherapy 
It consists in positioning a cryogenic probe into the nodule and then in its freezing up to a 
temperature between -100 and -196 degrees by using liquid nitrogen. The procedure lasts 
about 15 minutes until the tumor and healthy surrounding tissue frostbite is reached, 
through the development of cytoplasmic ice crystals, the cellular volume growth and the 
break of cytoplasmic membranes. Cold as a therapeutic agent against hepatocellular 
carcinoma makes also use of a particular cellular response to temperature decrease: 
cryoablation is able to inhibit cellular growth by stimulating a sort of cryoimmunity and by 
producing cytokines activating the natural killer cells, able to control tumor proliferation. 
This activation, typical of cryotherapy, is not visible in any other therapy against HCC.  
Cryotherapy allows to visualize with millimetric precision the limit between treated area 
and surroundings during routine radiologic controls. Low temperature action in facts is 
extremely zone-specific, and as it grows over the freezing limit for hepatic cells, it’s possible 
to meet healthy tissue, not damaged and well distinguishable from the treated area. So 
knowing exactly how much volume has been treated allows to plan possible further 
procedures. 
Cryotherapy, very promising, is now performed in the operatory room as a surgical time 
during hepatic resection. This is due to the dimension of probes, bigger than those of 
radiofrequency ablation. Technical evolution has brought to project and production of 
thinner probes, available for percutaneous use. This could make this technique available 
also for non-surgical patients in the immediate future9. 
Any of the two different approaches has of course pros and cons. Cryotherapy during 
surgery is made considering the possibility to explore all the parts of the abdomen and of 
the liver, looking for satellite nodules. Then, it’s possible the exact positioning of the probe 
into the tumor, even if it is in areas not reachable through percutaneous puncture or close to 
other organs. Percutaneous cryotherapy is possible also for outpatients, allows a rapid 
recovery and an easy pain control. Percutaneous treatment requires two therapy sessions9,10. 
A real comparison between cryotherapy and the most used percutaneous technique – 
radiofrequency – is difficult to be done. The most important reason is the fact that nowadays 
radiofrequency is performed mostly as an exclusive and percutaneous technique, while 
cryotherapy is still a therapeutic option during surgery. Anyways, there is a number of 
capabilities which might make it even more effective once reached an adequate technical 
ability. First, cryotherapy induces the production of a group of cytokines inhibiting cellular 
growth, while radiofrequency induces the production of substances stimulating the relapse 
of disease. Second, cryotherapy shows an exact limit between treated and non-treated areas, 
and then allows to control the adequacy of treatment, while radiofrequency creates a shaded 
border. Third, during cryotherapy it’s possible to verify, using ultrasounds, the blistering of 
ice crystals, and then assess the efficacy of therapy. Fourth, the procedure can be performed 
using multiple needles, without modifying the shape of the treated volume. 
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The most important complications typical of this procedure are the same of all the other 
percutaneous techniques. Using smaller probes than those used during intra-operatory 
approach (about 3.5 mm of diameter) has minimized the worst complication following 
cryotherapy, which is the rupture of the frozen area and then the following bleeding. Even if 
this event is possible after any cryogenic probe insertion, the probability of it is directly 
proportional to the dimension of the used needles. Another complication is the local and 
systemic thermic shock, with MOF and disseminated intravascular coagulation. In 
Literature this event has a risk of 1% of incidence using the old needles, close to 0% using 
the new smaller ones. 
As this is a new technique, and as it is now performed during surgery, it’s difficult to 
provide survival rates linked to its exclusive use. Anyways, in the Literature some Authors 
show a 3 years survival of about 35%11. 
2.5 Chemoembolization (TACE) 
This technique is performed through puncture of the common femoral artery and retrograde 
reach of a selected branch of the hepatic artery, or percutaneously through puncture of an 
infuse-a-port previously inserted into the right vessel. It consists in injecting resin 
microspheres linked to a chemotherapic drug (a cocktail of Mitomycin C, Adriamycin and 
Cisplatinum) or alone (in this case is correct to call the procedure not chemoembolization 
but only “embolization”). These spheres close the artery which provides blood to the liver 
volume in which there is the tumor. Occlusion causes an ischemic necrosis of the nodule and 
of the healthy surrounding tissue, and the presence of the chemotherapic drugs allows a 
lasting treatment. This technique is indicated especially for multifocal neoplasms, normally 
more than four nodules, but is useful also for a lower number of big lesions, or in any case 
of non surgical disease12. 
The possibility of using TACE for treatment of all the non surgical patients makes it good 
for those who would have a light  risk of liver failure in case of surgery, and this is the 
reason why this technique is a good option for all the Child B and C patients. More 
indications are the absence of vascular and periepatic infiltration and no extra-hepatic 
spread of disease. In all these cases, also according to the BCLC score, chemoembolization 
might be considered as a first line treatment for hepatocellular carcinoma. 
During the first therapeutic trials, in order to gain a complete treatment, big volumes of 
hepatic healthy tissue were embolized together with the neoplasm. This could bring to a real 
risk of organ failure, especially in those patients with low liver function. This is the reason 
why technological evolution has helped physicians to embolyze liver arteries in an always 
more selective way, thus trying to perform selective procedures, even less invasive. The 
collaboration between CT scan techniques and intra-operatory angiography allows the 
selection of  just the sub-segmentary arteries bringing blood to the lesion. Nowadays also 
the digital angiography is available, able to give clear images during the procedure, 
tridimensional if needed. Superselective chemoembolization, as it is performed in very little 
vessels, requires a new carrier of the chemotherapic drug. So, in this case it’s impossible to 
use the standard resin microspheres, but a different material, once used in radiology for 
hepatic contrast images and no longer in use, which is Lipiodol. This material, thick and 
able to link to HCC cells, has a disposition to settle and stay into the treated area, and it can 
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also be easily recognized also during a CT scan control without contrast because it is a 
radiological contrast by itself13. 
As said, chemoembolizing treatment is generally performed linking a drug to a resin 
microsphere. This process is obviously not necessary to obtain just the embolization of the 
blood vessel going to the tumor. There is a debate in the Literature whether there is a real 
need to link the drug to the resin, or not, as the resin alone is able to close the vessel and 
maybe to eliminate the lesion. Some studies show an almost comparable 3 years overall 
survival between the first and the second therapeutic option, some other suggest to perform 
a more complete procedure, and this is the reason why the discussion remains 
unresolved13,14. 
 
Fig. 4. A lesion following a TACE treatment seen with MR imaging 
Chemoembolization does not show the complications typical of the percutaneous 
procedures with direct tumor puncture. Anyways, considering the loss of healthy liver 
tissue after TACE, it’s mandatory to have a blood liver function test before performing the 
treatment, as destruction of a volume of liver, even if small in some cases, could bring to 
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organ failure. Moreover a pre-treatment angiographic study is required, looking for vascular 
anatomic variations or aberrant vessels, which could keep the lesion fed also after the 
procedure and cause a drug wash out. A pre-treatment angiographic study is important 
also, on the contrary, to look for anatomic variations to avoid possible ischemic necrosis of 
other organs close to the liver and not directly involved in the treatment. 
The characteristic possibility of TACE to treat also big lesions is the reason why survival 
after exclusive treatment is a direct consequence of neoplasm dimension. In case of small 
lesions a survival of 59% after 5 years is described. In case of nodules more than 5 
centimeters in diameter, 3 years and 5 years survival are respectively of 27% and 20%, as 
reported in the Literature15. 
2.6 Yttrium microspheres embolization 
This is a real and proper radioembolization, based on the finding that neoplastic liver tissue, as 
much as the metastatic one coming from other organs, is sensitive to therapeutic radiations. 
On the contrary, healthy liver tissue can be able to resist to cumulative doses even higher than 
3000 Gy. Radioembolization is performed using two possible devices, which are resin 
microspheres covered with 90Y, similar to those used for chemoembolization, or glass 
microspheres covered with the same radioactive material. In the USA, resin spheres are 
FDA authorized for any therapeutic use, while glass spheres are allowed only in case of 
non-surgical disease. In Europe both devices are allowed16. 
Procedures linked to the Yttrium microspheres treatment are strictly similar to those 
characteristic of chemoembolization, the only important difference is the fact the intra-
arterial drug injection does not require the vessel embolization.  In this way the production 
of some cytokines is avoided, among them there is also the factor 1α hypoxia induced and 
VEGF, able to stimulate the disease relapse over eventual not completely treated areas. This 
is the reason why there are some extended indications for this procedure in comparison 
with TACE: it’s possible to perform it even in case of Portal Vein thrombosis, which is a 
contraindication for chemoembolization as it could bring to ischemic hepatitis, and it’s 
particularly indicated for big lesions. Moreover, Yttrium microspheres appear easier to be 
tolerated than TACE, as they reduce post-treatment fever and post-chemotherapic diarrhea.  
On the contrary, patients who underwent this procedure often experience asthenia, and 
must be kept isolated for at least 24 hours as they are a source of ionizing dangerous waves. 
The general bearability of the treatment, anyways, makes it a valid option also for patients 
with a low performance status16,17. 
In the Literature there are always more papers trying to make a comparison between TACE 
and Yttrium microspheres. The two treatments are in facts quite similar, and results over 
disease free survival and overall survival are comparable. Today it’s still difficult to project 
equivalence studies, as they require a very big sample population to give significant statistic 
results. It’s demonstrated that radiometabolic treatment brings to an important 
improvement in terms of time to progression, which is the time between the treatment and 
the disease relapse. Moreover, if there is an adequate structure to accommodate them, older 
or weak people are some of the best patients to receive this treatment. 
In the end, considering the wide amount of contact points between TACE and Yttrium 
microspheres treatment, technical evolution is moving towards the creation of a unifying 
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method, creating a sort of radioembolization, able to present the good actions of the two 
procedures, avoiding the bad ones. 
Survival curves characteristic of Yttrium microspheres treatment as an exclusive one are 
quite the same of chemoembolization18. 
3. Conclusions 
Most of the techniques described have been performed in our institution, each one 
according to their indication, to treat hepatic lesions after surgery. We have noticed a 
growth of disease free survival and overall survival, experiencing how a combined 
approach to hepatocellular carcinoma is nowadays the most effective way to treat this 
disease. 
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